'Dragon's blood' sounds like the name of a single red resin obtained from one identifiable plant. In reality, the same commercial name has been applied to exudates from several botanically distant genera. For retailers, this diversity is essential: two products sold under the same name may have different origins, compositions and commercial histories.
Modern botanical and chemical research confirms this complexity. A review published in the Journal of Ethnopharmacology notes that the term dragon's blood has been used for resins or saps obtained from Dracaena, Daemonorops, Croton and Pterocarpus, among others. Other sources identify still more genera and commercial substitutes. The common name alone can therefore never identify the material reliably.
Why is it called 'dragon's blood'?
The name derives from the intense red colour of certain resins and ancient stories associating them with a dragon's blood. In the Mediterranean world, one of the best-known historical sources is Dracaena cinnabari, the dragon tree of Socotra. Its red resin was traded for centuries as a dye, medicinal material and valuable commodity.
However, historical and spectroscopic analyses show that other botanical sources soon entered the trade. Kew's economic botany collections contain samples from several genera. As trade networks expanded, 'dragon's blood' became more of a commercial category than a precise botanical identification.
This explains the confusion today. A packet of red powder sold in Europe may come from a climbing Asian palm formerly grouped under Daemonorops, a Dracaena or another plant. Without a reliable botanical name, origin and supplier, retailers cannot draw conclusions.
Dracaena cinnabari, the historic source from Socotra
Dracaena cinnabari grows naturally on the Yemeni island of Socotra. Its umbrella-shaped crown has become emblematic of the island. Scientific literature describes it as an ancient and prestigious source of red resin. This history explains why modern texts so readily associate dragon's blood with Socotra.
But this association does not mean every contemporary product comes from this species. Demand, scarcity, harvesting constraints and international trade encouraged substitutes. Product descriptions should only say 'Socotra dragon's blood' when the origin is genuinely established.
Environmental considerations also deserve special attention. Socotra's dragon trees belong to a fragile ecosystem. Their iconic status should not become an automatic sales argument. An impressive origin is no substitute for traceability or information about the supply chain.
Asian dragon's blood from palms
A substantial share of commercially traded dragon's blood has long been associated with Daemonorops draco, now placed in the genus Calamus in some classifications. Unlike Dracaena cinnabari, it is a climbing palm from Southeast Asia. The red resin is associated with the fruit and has a long trading history.
Kew preserves historical references to this material in its economic botany collections. Kew's Medicinal Plant Names Services also shows that the name 'dragon's blood' covers multiple scientific names and pharmaceutical or commercial uses. The database perfectly illustrates the risk of relying on common names.
For retailers, the practical consequence is that product form does not identify its source. Powder, chunks, granules and agglomerated resin may all have undergone processing. Dark red colour is not sufficient proof either. The botanical name remains the best starting point.
Croton, Pterocarpus and other sources
The term has also been applied to red saps from several Croton species, particularly in tropical America, and to products derived from Pterocarpus. These materials differ in both botany and commercial history. Some have been used in local traditional medicine, others as dyes or resins.
This diversity makes it inappropriate to take medicinal properties reported for one species and attribute them to every product sold as dragon's blood. A study of Dracaena cochinchinensis may document the chemistry of that species, but it establishes nothing about a product derived from an Asian palm or a South American Croton.
Every product description should follow the same rule: commercial names may be shared, but scientific findings apply to specifically identified materials.
Chemical differences are not merely laboratory details
Spectroscopic studies of Kew samples show that resins from Dracaena, Asian palms and Croton can be distinguished by their composition. For laboratories, these signatures help identify historical materials. For retailers, they show that visually similar products are not chemically interchangeable.
This difference directly affects health-related claims. A publication describing compounds in Dracaena cochinchinensis cannot justify attributing the same effects to a Calamus resin. Likewise, a traditional South American use of Croton should not be transferred to a product from Socotra.
In an esoteric product range, the best approach is to focus on identity, history, attributed ritual use and precautions specific to the product sold. Therapeutic claims should not be extrapolated.
Raw resin, powder, sticks and blends
Dragon's blood can reach shops in several forms. Raw resin retains irregular fragments. Powder has been ground, making visual identification harder. Some sticks or preparations may combine the resin with supports, gums or other materials.
Descriptions must therefore distinguish the material from the commercial form. 'Dragon's blood powder' does not automatically mean '100 % pure resin'. If the supplier specifies a preparation or mixture, include that information. If the exact composition is unavailable, avoid inventing a purity claim.
This information is useful for fumigation because behaviour when heated can vary with form and added ingredients. It also matters for pricing: comparing raw material with a processed preparation only by cost per gram is misleading.
How botanical identification improves the product range
In a shop, botanical precision builds trust. It explains why two dragon's blood products may differ in colour, texture or price. It also helps with traceability and substitutions when a supplier changes sources.
Our article on the supply chain for resins and plants already stresses this principle: cost and quality can only be analysed by comparing genuinely equivalent materials. Dragon's blood is a textbook example because one name covers very different substances.
In Esotericæ's catalogue, the Pure Resins and Incense Grains & Resins collections benefit from clearly distinguishing products whose botanical identity is known from those sold under traditional or commercial names.
Dragon's blood and ritual uses
In modern esoteric literature, dragon's blood is associated with protection, strength, love, amplifying other practices and fumigation. These uses may be described as part of particular traditions and contemporary currents, but should not be assigned a universal origin.
The fact that a resin was used as a dye or medicinal material in antiquity does not prove that it carried the same magical meanings found in today's occult books. Different historical layers must remain distinct.
For products intended for fumigation, descriptions should also mention combustion precautions. A resin is not risk-free simply because it is natural. Use a suitable burner, never leave charcoal unattended and ventilate the space in line with product and equipment instructions.
Check a batch without pretending to conduct botanical analysis
A shop is not a laboratory. It can nevertheless carry out simple checks: compare the appearance with the previous batch, check the scent, particle size, labelling, stated country of origin and supplier documents. A significant difference should prompt a question, not a definitive diagnosis.
If botanical identity is essential to a commercial claim, supplier documentation becomes indispensable. Where none exists, keep the description more restrained and refer to a commercial product sold under the name dragon's blood.
Such transparency is preferable to a false Latin identification copied from another shop. It protects the credibility of the category and makes supplier changes easier.
How to buy without falling into the commercial-name trap
When making trade purchases, request the botanical name, country of harvesting or processing, extraction method and, if possible, a technical sheet or other supplier documentation. If the supplier can only say 'natural dragon's blood', treat that as insufficient information to state a precise origin.
Goods receiving should also check batch consistency. Changes in colour, hardness or fragrance may suggest a material variation but are not, on their own, evidence of fraud. Compare the documentation and ask the supplier before reaching a conclusion.
Our guide to checking supplier deliveries provides a method that can be used for this type of material.
A fascinating material precisely because it is not one material
Dragon's blood is interesting because it makes us look beyond the commercial name. It connects Socotra, Southeast Asia, China, tropical America and several histories of the resin trade. That richness disappears when a product listing reduces it to an 'enchanted red resin' with no origin.
For professional retailers, the aim is not to make selling more complicated but to give customers reliable information. A precise label identifying the species and origin is more valuable than an accumulation of unverifiable correspondences.
Avoid shortcuts connecting colour, purity and authenticity
Colour is one of the most common traps. A very bright red does not necessarily prove superior quality, while a reddish-brown shade does not prove a resin is poor. Colour depends on botanical source, age, particle size, preparation method and the lighting in which the product is viewed.
Powder makes this even more difficult. A ground material may appear more uniform than raw fragments and hide visual differences. Trade purchasing should therefore rely on documentation and supplier consistency rather than a simple comparison of photographs.
Finally, the adjective 'pure' should only be used when the composition supports it. A fumigation preparation may be entirely legitimate while containing other materials. The problem is not the mixture itself but a lack of information about what is actually being sold.
A good product title can clarify the source without complicating the sale
When the species is known, the product title can remain simple while including a parenthetical clarification, for example 'Dragon's Blood — Dracaena Resin' or 'Dragon's Blood — Asian Palm Resin'. This retains the name customers search for while immediately introducing the botanical distinction.
When the species is unconfirmed, it is better to retain the commercial name and explain in the description that several sources exist. Open caution is more professional than invented precision, especially for a material whose commercial history is defined by substitution and shared names.
Sources and references
Gupta, Bleakley & Gupta — Dragon's blood: botany, chemistry and therapeutic uses, Journal of Ethnopharmacology, 2008. Review of the botanical sources known as dragon's blood.
Edwards, de Oliveira & Prendergast — Raman spectroscopic analysis of dragon's blood resins, study of historical samples from Kew's collections.
Ethnobotanical Survey of Dracaena cinnabari. Introduction to Socotra resin and its commercial history.
Kew Medicinal Plant Names Services — dragon's blood. Database illustrating the multiple botanical sources associated with the common name.